Company · CIK 0001337553 · SIC 2836 — Biological Products, (No Diagnostic Substances)
AERIE PHARMACEUTICALS INC · AERI
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 8, 2015 SForm 4 → | Jan 12, 9:44 am EST | Clarus Lifesciences II, L.P. +810% Owner | 175,000 | $31.11 | $5,444,250 | 3,324,259 | −5.00% | plan? |
| Jan 5, 2015 SForm 4 → | Jan 6, 3:41 pm EST | Clarus Lifesciences II, L.P. +810% Owner | 23,620 | $30.86 | $728,913 | 3,499,259 | −0.67% | plan? |
| Oct 25, 2013 PForm 4/A → | Jan 30, 2015, 5:39 pm EST | Clarus Lifesciences II, L.P. +810% Owner | 321,000 | $10.00 | $3,210,000 | 3,468,494 | +10.2% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 7, 2019 AForm 4 → | Feb 11, 5:28 pm EST | John LaRoccaGeneral Counsel | 31,000 | — | — | 31,000 | — | |
| Feb 7, 2019 AForm 4 → | Feb 11, 5:27 pm EST | Casey C. KopczynskiChief Scientific Officer | 36,000 | — | — | 36,000 | — | |
| Feb 7, 2019 AForm 4 → | Feb 11, 5:26 pm EST | Vicente Anido Jr.Chief Executive Officer, Director | 114,358 | — | — | 114,358 | — | |
| Feb 7, 2019 AForm 4 → | Feb 11, 5:25 pm EST | Thomas A MitroPresident and COO | 57,500 | — | — | 57,500 | — | |
| Feb 7, 2019 AForm 4 → | Feb 11, 5:23 pm EST | Richard J RubinoChief Financial Officer | 48,000 | — | — | 48,000 | — | |
| Sep 12, 2018 AForm 4 → | Sep 12, 5:14 pm EDT | David W GryskaDirector | 25,000 | — | — | 25,000 | — | |
| Aug 27, 2018 MForm 4 → | Aug 29, 4:02 pm EDT | Thomas A MitroPresident and COO | 190,000 | — | — | 63,498 | — | |
| Jun 11, 2018 MForm 4 → | Jun 13, 4:33 pm EDT | Vicente Anido Jr.Chief Executive Officer, Director | 50,000 | — | — | 846,329 | — | |
| Jun 7, 2018 AForm 4 → | Jun 8, 8:07 pm EDT | Benjamin F McGraw IIIDirector | 7,800 | — | — | 7,800 | — | |
| Jun 7, 2018 AForm 4 → | Jun 8, 8:06 pm EDT | Murray A GoldbergDirector | 7,800 | — | — | 7,800 | — | |
| Jun 7, 2018 AForm 4 → | Jun 8, 8:04 pm EDT | Michael du ToitDirector | 7,800 | — | — | 7,800 | — | |
| Jun 7, 2018 AForm 4 → | Jun 8, 8:00 pm EDT | Richard CroarkinDirector | 7,800 | — | — | 7,800 | — | |
| Jun 7, 2018 AForm 4 → | Jun 8, 7:58 pm EDT | Gerald D. CagleDirector | 7,800 | — | — | 7,800 | — | |
| Jun 7, 2018 AForm 4 → | Jun 8, 7:56 pm EDT | Julie McHughDirector | 7,800 | — | — | 7,800 | — | |
| Jun 6, 2018 MForm 4 → | Jun 8, 7:44 pm EDT | Vicente Anido Jr.Chief Executive Officer, Director | 150,000 | — | — | 896,329 | — | |
| May 24, 2018 MForm 4 → | May 29, 5:54 pm EDT | Casey C. KopczynskiChief Scientific Officer | 3,000 | — | — | 0 | — | |
| Feb 19, 2018 AForm 4 → | Feb 21, 4:08 pm EST | John LaRoccaGeneral Counsel | 70,000 | — | — | 70,000 | — | |
| Feb 9, 2018 MForm 4 → | Nov 2, 4:02 pm EDT | Casey C. KopczynskiChief Scientific Officer | 3,251 | — | — | 0 | — | late |
| Feb 8, 2018 AForm 4 → | Feb 12, 6:03 pm EST | Richard J RubinoChief Financial Officer | 48,000 | — | — | 48,000 | — | |
| Feb 8, 2018 AForm 4 → | Feb 12, 6:03 pm EST | Thomas A MitroPresident and COO | 57,500 | — | — | 57,500 | — | |
| Feb 8, 2018 AForm 4 → | Feb 12, 6:01 pm EST | Casey C. KopczynskiChief Scientific Officer | 36,000 | — | — | 36,000 | — | |
| Feb 8, 2018 AForm 4 → | Feb 12, 6:00 pm EST | Vicente Anido Jr.Chief Executive Officer, Director | 114,358 | — | — | 114,358 | — | |
| Jun 8, 2017 AForm 4 → | Jun 9, 4:10 pm EDT | Richard CroarkinDirector | 10,000 | — | — | 10,000 | — | |
| Jun 8, 2017 AForm 4 → | Jun 9, 4:09 pm EDT | Gerald D. CagleDirector | 10,000 | — | — | 10,000 | — | |
| Jun 8, 2017 AForm 4 → | Jun 9, 4:08 pm EDT | Michael du ToitDirector | 10,000 | — | — | 10,000 | — | |
| Jun 8, 2017 AForm 4 → | Jun 9, 4:07 pm EDT | Murray A GoldbergDirector | 10,000 | — | — | 10,000 | — | |
| Jun 8, 2017 AForm 4 → | Jun 9, 4:07 pm EDT | Benjamin F McGraw IIIDirector | 10,000 | — | — | 10,000 | — | |
| Jun 8, 2017 AForm 4 → | Jun 9, 4:06 pm EDT | Julie McHughDirector | 10,000 | — | — | 10,000 | — | |
| Feb 23, 2017 AForm 4 → | Feb 27, 6:25 pm EST | Richard J RubinoChief Financial Officer | 43,019 | — | — | 43,019 | — | |
| Feb 23, 2017 AForm 4 → | Feb 27, 6:23 pm EST | Thomas A MitroPresident and COO | 79,418 | — | — | 79,418 | — | |
| Feb 23, 2017 AForm 4 → | Feb 27, 6:22 pm EST | Casey C. KopczynskiChief Scientific Officer | 39,709 | — | — | 39,709 | — | |
| Feb 23, 2017 AForm 4 → | Feb 27, 6:20 pm EST | Vicente Anido Jr.Chief Executive Officer, Director | 155,528 | — | — | 155,528 | — | |
| Feb 14, 2017 MForm 4 → | Feb 16, 4:03 pm EST | Geoffrey M DuykDirector | 58,167 | — | — | 0 | — | |
| Jun 8, 2016 AForm 4 → | Jun 9, 4:36 pm EDT | Gerald D. CagleDirector | 10,000 | — | — | 10,000 | — | |
| Jun 8, 2016 AForm 4 → | Jun 9, 4:35 pm EDT | Richard CroarkinDirector | 10,000 | — | — | 10,000 | — | |
| Jun 8, 2016 AForm 4 → | Jun 9, 4:34 pm EDT | Michael du ToitDirector | 10,000 | — | — | 10,000 | — | |
| Jun 8, 2016 AForm 4 → | Jun 9, 4:34 pm EDT | Geoffrey M DuykDirector | 10,000 | — | — | 10,000 | — | |
| Jun 8, 2016 AForm 4 → | Jun 9, 4:33 pm EDT | Murray A GoldbergDirector | 10,000 | — | — | 10,000 | — | |
| Jun 8, 2016 AForm 4 → | Jun 9, 4:32 pm EDT | Benjamin F McGraw IIIDirector | 10,000 | — | — | 10,000 | — | |
| Jun 8, 2016 AForm 4 → | Jun 9, 4:31 pm EDT | Julie McHughDirector | 10,000 | — | — | 10,000 | — | |
| Feb 24, 2016 AForm 4 → | Mar 1, 10:35 am EST | Richard J RubinoChief Financial Officer | 60,000 | — | — | 60,000 | — | late |
| Feb 24, 2016 AForm 4 → | Mar 1, 10:35 am EST | Thomas A MitroPresident and COO | 71,250 | — | — | 71,250 | — | late |
| Feb 24, 2016 AForm 4 → | Mar 1, 10:34 am EST | Casey C. KopczynskiChief Scientific Officer | 51,000 | — | — | 51,000 | — | late |
| Feb 24, 2016 AForm 4 → | Mar 1, 10:33 am EST | Vicente Anido Jr.Chief Executive Officer, Director | 150,504 | — | — | 150,504 | — | late |
| Jun 29, 2015 AForm 4 → | Jul 6, 9:58 am EDT | Julie McHughDirector | 25,000 | — | — | 25,000 | — | late |
| Jun 29, 2015 AForm 4 → | Jul 1, 3:08 pm EDT | Michael du ToitDirector | 25,000 | — | — | 25,000 | — | |
| Jun 15, 2015 MForm 5 → | Feb 27, 2017, 6:15 pm EST | Casey C. KopczynskiChief Scientific Officer | 4,596 | — | — | 0 | — | |
| May 7, 2015 AForm 4 → | May 11, 1:42 pm EDT | Richard CroarkinDirector | 25,000 | — | — | 25,000 | — | |
| Apr 14, 2015 XForm 4 → | Apr 16, 7:23 pm EDT | Anand MehraDirector | 150,000 | — | — | 0 | — | |
| Apr 10, 2015 AForm 4 → | Apr 14, 6:54 pm EDT | David W GryskaDirector | 10,000 | — | — | 10,000 | — | |
| Apr 10, 2015 AForm 4 → | Apr 14, 6:51 pm EDT | Anand MehraDirector | 10,000 | — | — | 10,000 | — | |
| Apr 10, 2015 AForm 4 → | Apr 14, 6:51 pm EDT | Benjamin F McGraw IIIDirector | 10,000 | — | — | 10,000 | — | |
| Apr 10, 2015 AForm 4 → | Apr 14, 6:46 pm EDT | Murray A GoldbergDirector | 10,000 | — | — | 10,000 | — | |
| Apr 10, 2015 AForm 4 → | Apr 14, 6:45 pm EDT | Geoffrey M DuykDirector | 10,000 | — | — | 10,000 | — | |
| Apr 10, 2015 AForm 4 → | Apr 14, 6:43 pm EDT | Gerald D. CagleDirector | 10,000 | — | — | 10,000 | — | |
| Feb 25, 2015 AForm 4 → | Feb 27, 6:31 pm EST | Richard J RubinoChief Financial Officer | 54,375 | — | — | 54,375 | — | |
| Feb 25, 2015 AForm 4 → | Feb 27, 6:29 pm EST | Thomas A MitroPresident and COO | 71,250 | — | — | 71,250 | — | |
| Feb 25, 2015 AForm 4 → | Feb 27, 6:28 pm EST | Brian LevyChief Medical Officer | 61,875 | — | — | 61,875 | — | |
| Feb 25, 2015 AForm 4 → | Feb 27, 6:27 pm EST | Casey C. KopczynskiChief Scientific Officer | 43,125 | — | — | 43,125 | — | |
| Feb 25, 2015 AForm 4 → | Feb 27, 6:25 pm EST | Vicente Anido Jr.Chief Executive Officer, Director | 133,125 | — | — | 133,125 | — | |
| Oct 25, 2013 CForm 4/A → | Jan 30, 2015, 5:39 pm EST | Clarus Lifesciences II, L.P. +810% Owner | 369,624 | — | — | 0 | — |